
GBS GBS
Quartalsbericht 2025-Q4
hinzugefügt 12.02.2026
GBS EV/EBITDA 2011-2026 | GBS
EV/EBITDA Jährlich GBS
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.03 | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.03 | 1.03 | 1.03 |
EV/EBITDA anderer Aktien in der Medizinische Geräte
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
ClearPoint Neuro
CLPT
|
-9.73 | $ 8.99 | -4.16 % | $ 255 M | ||
|
EDAP TMS S.A.
EDAP
|
730 | $ 3.45 | -0.29 % | $ 129 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
11 | $ 12.01 | -0.5 % | $ 1.62 B | ||
|
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M | ||
|
FONAR Corporation
FONR
|
-33.4 | $ 18.6 | - | $ 122 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
-2.13 | $ 36.14 | -1.65 % | $ 5.38 K | ||
|
Globus Medical
GMED
|
27.6 | $ 90.07 | 1.66 % | $ 12.2 B | ||
|
Helius Medical Technologies
HSDT
|
-0.0925 | $ 1.78 | -6.32 % | $ 1.08 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
29.6 | $ 9.27 | -0.43 % | $ 714 M | ||
|
Inspire Medical Systems
INSP
|
-152 | $ 54.06 | -0.15 % | $ 1.59 B | ||
|
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | ||
|
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.01 | 1.34 % | $ 17.1 M | ||
|
Integer Holdings Corporation
ITGR
|
18.2 | $ 85.48 | -0.18 % | $ 2.97 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-165 | $ 15.68 | -1.63 % | $ 368 M | ||
|
LENSAR
LNSR
|
-1.48 | $ 5.83 | -1.1 % | $ 69.7 M | ||
|
Medtronic PLC
MDT
|
24.4 | $ 86.15 | -0.15 % | $ 111 B | ||
|
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | ||
|
Myomo
MYO
|
-2.96 | $ 0.66 | -5.68 % | $ 27.6 M | ||
|
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | ||
|
Align Technology
ALGN
|
48.9 | $ 166.53 | -3.11 % | $ 12.5 B | ||
|
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | ||
|
Orthofix Medical
OFIX
|
31.1 | $ 11.68 | -0.76 % | $ 463 M | ||
|
AxoGen
AXGN
|
-19.1 | $ 30.86 | -5.45 % | $ 1.42 B | ||
|
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | ||
|
Penumbra
PEN
|
938 | $ 329.86 | - | $ 12.8 B | ||
|
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | ||
|
Insulet Corporation
PODD
|
95.3 | $ 202.45 | -0.52 % | $ 14.2 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M | ||
|
Sintx Technologies
SINT
|
0.974 | $ 2.53 | - | $ 7.02 M | ||
|
Butterfly Network
BFLY
|
-3.9 | $ 4.03 | -2.54 % | $ 853 M | ||
|
Smith & Nephew plc
SNN
|
24.9 | $ 31.63 | -3.06 % | $ 23.8 B | ||
|
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | ||
|
Stryker Corporation
SYK
|
30 | $ 330.34 | -0.59 % | $ 126 B | ||
|
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.59 | 0.76 % | $ 36.7 M | ||
|
Tactile Systems Technology
TCMD
|
241 | $ 24.31 | -1.06 % | $ 556 M | ||
|
TELA Bio
TELA
|
-5.89 | $ 0.67 | 6.38 % | $ 31.5 M | ||
|
TransMedics Group
TMDX
|
-12.1 | $ 106.65 | 1.77 % | $ 3.63 B | ||
|
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | ||
|
Tandem Diabetes Care
TNDM
|
215 | $ 19.31 | 0.74 % | $ 1.31 B | ||
|
Delcath Systems
DCTH
|
-1.69 | $ 9.64 | -0.67 % | $ 345 M | ||
|
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
25.2 | $ 60.97 | -2.6 % | $ 90.3 B |